Several studies have validated the hypothesis that preeclampsia arises due to ‘increase in the level of endogenous soluble Flt-1 (sFlt-1) that may antagonize the beneficial effects of vascular endothelial growth factor (VEGF)’[[10], [11], [12], [13]]. This evidence concerns the gene FLT1 and preeclampsia.